Director, Market Access, Poland

Revolution Medicines, Inc.; United States; Remote; USD 90,000 - 154,000; Full time

Job summary

Revolution Medicines is seeking a Market Access Director, Poland to lead access and reimbursement strategies for launches within the Polish healthcare system. You will shape HTA submissions, pricing negotiations, and value communications for payers, while partnering with regional teams to align European objectives.

You will build relationships with payers and authorities, oversee policy monitoring, and drive cross-functional collaboration to accelerate payer access for oncology products across

Qualifications

• Lead market access and reimbursement strategies for Poland launches.
• Lead HTA value dossiers and pricing negotiations with payers.
• Translate clinical/economic evidence into payer-facing communications.

Responsibilities

• Lead Market Access & Reimbursement strategy for Poland.
• Lead HTA filings and pricing negotiations with payers.
• Partner with regional Medical Affairs and Marketing to tailor value communications for Poland payers.
• Represent Revolution Medicines with payers, HTA authorities and policy influencers.
• Align local access strategy with European/regional objectives.
• Provide early market access input to regional clinical development and medical teams.
• Lead negotiations with national payers across all levels.
• Develop innovative pricing and value-based contracting models.
• Monitor health policy developments and reimbursement environments.
• Represent Market Access in Poland Leadership Team meetings.
• Drive access and value projects like landscape assessments and payer research.
• Develop outreach plans for key payers and launch readiness.

Skills

Market access strategy

HTA submissions

Payer engagement

Pricing strategy

Stakeholder management

Cross-functional collaboration

Education

Advanced degree in Life Sciences

Job description

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

The Market Access Director, Poland is responsible for defining and executing the country market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. This role shapes reimbursement and access strategy, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities.

This position will partner with regulatory, commercial and medical affairs teams to deliver launch activities by providing access insights, developing evidence-based HTA, Pricing & Reimbursement dossiers and tools, engaging with market access and public affairs stakeholders as well as driving pricing strategy activities, and lead the activities to deliver access results supporting the overall success of the product launches aligned with patient needs.

Required Skills, Experience and Education:

• Lead Market Access & Reimbursement: Develop and implement strategies to support access and pricing decisions for RevMed portfolio and launches within the Poland healthcare system.

• HTA & Pricing Filings: Lead preparation and submission of value dossiers, benefit assessments and pricing negotiations with statutory health insurance decision makers.

• Partner with regional and local Medical Affairs and Marketing team to translate clinical and economic evidence into compelling value communications tailored for Poland payers.

• Build and maintain strong relationships with key external stakeholders (payers, HTA authorities, policy influencers). Representation of Revolution Medicines at local trade associations for market access subjects.

• Work with Midsized Markets and Regional Market Access teams to align local access strategy with broader European and corporate objectives, especially in terms of aligning the European regulatory strategy and execution with local value dossier submission and pricing negotiation strategy.

• Provide early market access input to regional and European clinical development and medical teams.

• Lead negotiation with all levels of national payers.

• Develop innovative pricing and value based contracting models to optimize the acceleration of reimbursement approvals.

• Policy Monitoring: Monitor health policy developments, HTA processes and local reimbursement environments to inform strategy.

• Represent Market Access in Poland Leadership Team meetings and contribute to overall business strategy.

• Drive access and value related projects such as landscape assessments, payer market research, payer advisory boards and general guidance on local strategies.

• Development of outreach and engagement plan for key payers creating and maintaining a strong network.

• Early access planning of new products and indications, drive launch readiness for multiple oncology assets (portfolio responsibility).

• Influence European and Midsised Markets access strategy based on local payer insights from a leadership position.

• Travel nationally and internationally.

Preferred Skills:

• Advanced degree (e.g., Life Sciences, Pharmacy, Health Economics, Public Health).

• A minimum of 10 years’ experience in market access, pricing, reimbursement or health economics (pharma/biotech) in Poland.

• Proven value and benefit assessment experience, with deep understanding of Poland payer decision-making.

• Demonstrated success and experience supporting oncology product pre-launch, launch and post launch in Poland.

• Demonstrated success in negotiating pricing and reimbursement conditions with public administrations and health authorities.

• Strong stakeholder management and ability to collaborate with internal and external partners.

• Excellent interpersonal and communication skills.

• Scientific and solution-oriented mindset and capability to move and execute in a rapidly changing, ambiguous environment.

• Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments.

• Experience in a biotech and/or in a build-out.

• High capacity of social competence for teamwork, coaching and situational leadership.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA NoticeandPrivacy Policy. For additional information, please contact [e-mail].